Johnson & Johnson Completes Acquisition of Intra-Cellular Therapies
US-based Johnson & Johnson (NYSE: JNJ) announced the completion of its acquisition of fellow American...
US-based Johnson & Johnson (NYSE: JNJ) announced the completion of its acquisition of fellow American...
Beijing Yuewei Medical Technology Co., Ltd, a medical device company specializing in coronary heart disease,...
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) has entered...
China-based Sinovac Biotech Ltd (NASDAQ: SVA) has entered into a strategic memorandum of understanding (MoU)...
The Sanofi Cathy Capital Pharmaceutical Innovation Fund, a joint venture between French pharmaceutical giant Sanofi...
Japan-based Shionogi Co., Ltd. has entered into an exclusive licensing agreement with Link Medical Products...
China-based WuXi XDC (HKG: 2268), a joint venture between WuXi Biologics (HKG: 2269) and WuXi...
US pharmaceutical giant Pfizer Inc. (NYSE: PFE) has entered into a collaboration agreement with Flagship...
US-based targeted protein degradation (TPD) specialist Nurix Therapeutics, Inc. (NASDAQ: NRIX) announced an expanded partnership...
Organon (NYSE: OGN) announced today that it has acquired regulatory and commercial rights in the...
On April 2, 2025, ChemPartner Pharmatech (SHE: 300149) announced plans to issue shares to a...
Peijia Medical Technology (Suzhou) Co., Ltd. today held a strategic innovation cooperation signing ceremony and...
Medtronic announced a strategic partnership with Methinks AI, a leading provider of AI-driven radiological triage...
Renji Hospital, a comprehensive Class 3A hospital established in 1844 in Shanghai, has partnered with...
US medical device and life sciences giant GE Healthcare Technologies Inc., (NASDAQ: GEHC) announced that...
Chinese companies Nanjing F&S Pharmatech Co., Ltd and Hunan Huize Biopharmaceutical Technology Co., Ltd, a...
China-based Annoroad Gene Technology (Beijing) Co., Ltd. has submitted an initial public offering (IPO) filing...
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) announced that its German partner Merck KGaA...
China-based Chia Tai Tianqing Pharmaceutical has entered into a Named Patient Program (NPP) collaboration with...
China-based Pacific Shuanglin Bio-pharmacy Co., Ltd (SHE: 000403) has formed a strategic partnership with Shenzhen-based...